Rybelsus stands out as an innovative medication for managing diabetes, particularly type 2 diabetes. Developed by Novo Nordisk, Rybelsus uses semaglutide as its active ingredient and represents a new class of drugs known as GLP-1 receptor agonists. This oral medication has gained attention for its ability to effectively lower blood…